Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Arquivos Brasileiros De Cardiologia
|
April 22, 2005
[Single coronary artery: angioplasty with stent implantation]
lan C D Teixeira, Alexandre X Brant, Alexandre Ares, et al.
Journal of the American Academy of Dermatology
|
May 25, 2023
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Andrew Blauvelt, Barry Ladizinski, Vimal H Prajapati, et al.
The Journal of Endocrinology
|
October 3, 2025
Lactobacillus johnsonii N6.2 improves glycemia and reduces diabetes-induced organ injury in the db/db mice model
Monica F Torrez Lamberti, Sharon Thompson, Natalie A Harrison, et al.
Meat Science
|
October 16, 2021
Effect of vitamin A injection at birth on intramuscular fat development and meat quality in beef cattle
Felipe C Maciel, Otávio R Machado Neto, Marcio S Duarte, et al.
Brain Research
|
November 27, 2022
Animal model of Alzheimer's disease induced by streptozotocin: New insights about cholinergic pathway
Saritha S L Silva, Luciane V Tureck, Leonardo C Souza, et al.
The Journal of Hospital Infection
|
August 30, 2021
Explosive nosocomial outbreak of SARS-CoV-2 in a rehabilitation clinic: the limits of genomics for outbreak reconstruction
M Abbas, T Robalo Nunes, A Cori, et al.
Lancet (London, England)
|
May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Kristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
JAMA Dermatology
|
August 4, 2021
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Andrew Blauvelt, Henrique D Teixeira, Eric L Simpson, et al.
The British Journal of Dermatology
|
March 28, 2019
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials
G B E Jemec, M M Okun, S B Forman, et al.
Critical Care Explorations
|
March 10, 2022
The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop
Susanne Muehlschlegel, Sarah M Perman, Jonathan Elmer, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Arquivos Brasileiros De Cardiologia
|
April 22, 2005
[Single coronary artery: angioplasty with stent implantation]
lan C D Teixeira, Alexandre X Brant, Alexandre Ares, et al.
Journal of the American Academy of Dermatology
|
May 25, 2023
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Andrew Blauvelt, Barry Ladizinski, Vimal H Prajapati, et al.
The Journal of Endocrinology
|
October 3, 2025
Lactobacillus johnsonii N6.2 improves glycemia and reduces diabetes-induced organ injury in the db/db mice model
Monica F Torrez Lamberti, Sharon Thompson, Natalie A Harrison, et al.
Meat Science
|
October 16, 2021
Effect of vitamin A injection at birth on intramuscular fat development and meat quality in beef cattle
Felipe C Maciel, Otávio R Machado Neto, Marcio S Duarte, et al.
Brain Research
|
November 27, 2022
Animal model of Alzheimer's disease induced by streptozotocin: New insights about cholinergic pathway
Saritha S L Silva, Luciane V Tureck, Leonardo C Souza, et al.
The Journal of Hospital Infection
|
August 30, 2021
Explosive nosocomial outbreak of SARS-CoV-2 in a rehabilitation clinic: the limits of genomics for outbreak reconstruction
M Abbas, T Robalo Nunes, A Cori, et al.
Lancet (London, England)
|
May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Kristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
JAMA Dermatology
|
August 4, 2021
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Andrew Blauvelt, Henrique D Teixeira, Eric L Simpson, et al.
The British Journal of Dermatology
|
March 28, 2019
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials
G B E Jemec, M M Okun, S B Forman, et al.
Critical Care Explorations
|
March 10, 2022
The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop
Susanne Muehlschlegel, Sarah M Perman, Jonathan Elmer, et al.
Page
of 14